Top

Reactions Weekly

Published in:

01-05-2020 | Graft-Versus-Host Disease | Case report

Lenalidomide/mogamulizumab

Various toxicities: 8 case reports

Published in: Reactions Weekly | Issue 1/2020

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Sakamoto H, et al. Treatment with mogamulizumab or lenalidomide for relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience. Hematological Oncology 38: 162-170, No. 2, Apr 2020. Available from: URL: http://doi.org/10.1002/hon.2712 CrossRef

Title: Lenalidomide/mogamulizumab
Various toxicities: 8 case reports
Publication date: 01-05-2020
Publisher: Springer International Publishing
Keywords: Graft-Versus-Host Disease
Graft-Versus-Host Disease
Published in: Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-78893-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Lenalidomide/mogamulizumab

Various toxicities: 8 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

Digoxin

Rifampicin/tacrolimus interaction

Gentamicin/tobramycin/vancomycin interaction

Hydroxychloroquine

Prednisolone

Andexanet-α